The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial
- 7 November 2011
- journal article
- research article
- Published by SAGE Publications in Clinical Trials
- Vol. 9 (2) , 257-264
Abstract
Background Compliance with Good Clinical Practice (GCP) guidelines should ensure the safety of trial participants and the reliability of trial results. Over the last decade, increasing emphasis has been placed on the role of costly on-site monitoring and source data verification as processes to demonstrate that GCP is being followed, despite a lack of empirical evidence that these are effective.Keywords
This publication has 18 references indexed in Scilit:
- Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon studyContemporary Clinical Trials, 2010
- Risk analysis and risk adapted on-site monitoring in noncommercial clinical trialsClinical Trials, 2009
- Quality management of a large randomized double-blind multi-centre trial: The ACTION experienceContemporary Clinical Trials, 2008
- Specific barriers to the conduct of randomized trialsClinical Trials, 2008
- Ensuring trial validity by data quality assurance and diversification of monitoring methodsClinical Trials, 2008
- Sensible guidelines for the conduct of large randomized trialsClinical Trials, 2008
- Clinical trials bureaucracy: unintended consequences of well-intentioned policyClinical Trials, 2006
- The other side of clinical trial monitoring; assuring data quality and procedural adherenceClinical Trials, 2006
- Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancerClinical Trials, 2006
- The Good Clinical Practice guideline: a bronze standard for clinical researchThe Lancet, 2005